QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.110247v1 319/3/1191    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deng, X. Articles by Roth, R. A. Search for Related Content PubMed PubMed Citation Articles by Deng, X. Articles by Roth, R. A.

TOXICOLOGY

Modest Inflammation Enhances Diclofenac Hepatotoxicity in Rats: Role of Neutrophils and Bacterial Translocation

Department of Biochemistry and Molecular Biology (X.D.), and Department of Pharmacology and Toxicology (J.P.L., J.F.M., P.E.G., R.A.R.), Michigan State University, East Lansing, Michigan; Department of Discovery Safety, Metabolism and Pharmacokinetics, Abbott Bioresearch Center, Worcester, Massachusetts (R.F.S.); and Department of Molecular and Cellular Toxicology, Abbott Laboratories, Abbott Park, Illinois (M.J.L., E.A.G.B., J.F.W.)

Idiosyncratic adverse drug reactions (IADRs) represent an important human health problem, yet animal models for preclinical prediction of these reactions are lacking. Recent evidence in animals suggests that some IADRs arise from drug interaction with an inflammatory episode that renders the liver sensitive to injury. Diclofenac (DCLF) is one of those drugs for which the clinical use is limited by idiosyncratic liver injury. We tested the hypothesis that modest inflammation triggered in rats by a small dose of lipopolysaccharide (LPS) renders a nonhepatotoxic dose of DCLF injurious to liver. Cotreatment of rats with nonhepatotoxic doses of LPS and DCLF resulted in elevated serum alanine aminotransferase activity and liver histopathologic changes 6 h after DCLF administration. Neither LPS nor DCLF alone had such an effect. Gene array analysis of livers revealed a unique gene expression pattern in the LPS/DCLF-cotreated group compared with groups given either agent alone. Antiserum-induced neutrophil (PMN) depletion in LPS/DCLF-cotreated rats protected against liver injury, demonstrating a role for PMNs in the pathogenesis of this LPS/DCLF interaction. Gut sterilization of LPS/DCLF-treated rats did not protect against liver injury. In contrast, gut sterilization did attenuate liver injury caused by a large, hepatotoxic dose of DCLF, suggesting that hepatotoxicity induced by large doses of DCLF is caused in part by its ability to increase intestinal permeability to endotoxin or other bacterial products. These results demonstrate that inflammation-DCLF interaction precipitates hepatotoxicity in rats and raise the possibility of creating animal models that predict human IADRs.

Address correspondence to: Dr. Robert A. Roth, Department of Pharmacology and Toxicology, Michigan State University, Room 221, Food Safety and Toxicology Building, Michigan State University, East Lansing, MI 48824 E-mail: rothr{at}msu.edu

This article has been cited by other articles:

				K. H. Yang, Y. S. Jung, D. Y. Lee, J. H. Lee, Y. C. Kim, and M. G. Lee Time-Dependent Effects of Klebsiella Pneumoniae Endotoxin (KPLPS) on the Pharmacokinetics of Theophylline in Rats: Return of the Parameters in 96-Hour KPLPS Rats to the Control Levels Drug Metab. Dispos., May 1, 2008; 36(5): 811 - 815. [Abstract] [Full Text] [PDF]

				P. J. Shaw, M. J. Hopfensperger, P. E. Ganey, and R. A. Roth Lipopolysaccharide and Trovafloxacin Coexposure in Mice Causes Idiosyncrasy-Like Liver Injury Dependent on Tumor Necrosis Factor-Alpha Toxicol. Sci., November 1, 2007; 100(1): 259 - 266. [Abstract] [Full Text] [PDF]